RRC ID |
64617
|
著者 |
Zhou Q, Tian W, Jiang Z, Huang T, Ge C, Liu T, Zhao F, Chen T, Cui Y, Li H, Yao M, Li J, Tian H.
|
タイトル |
A Positive Feedback Loop of AKR1C3-Mediated Activation of NF-κB and STAT3 Facilitates Proliferation and Metastasis in Hepatocellular Carcinoma.
|
ジャーナル |
Cancer Res
|
Abstract |
AKR1C3 is an enzyme belonging to the aldo-ketoreductase family, the members of which catalyze redox transformations involved in biosynthesis, intermediary metabolism, and detoxification. AKR1C3 plays an important role in tumor progression and metastasis, however, little is known about the function and the molecular mechanism underlying the role of AKR1C3 in hepatocellular carcinoma (HCC). In this study, we report that AKR1C3 is significantly upregulated in HCC and that increased AKR1C3 is associated with poor survival. AKR1C3 positively regulated HCC cell proliferation and metastasis in vitro and in vivo. AKR1C3 promoted tumor proliferation and metastasis by activating NF-κB signaling. Furthermore, AKR1C3 regulated NF-κB activity by modulating TRAF6 and inducing its autoubiquitination in HCC cells. Activation of NF-κB released proinflammatory factors that facilitated the phosphorylation of STAT3 and increased tumor cell proliferation and invasion. Gain- and loss-of-function experiments showed that AKR1C3 promoted tumor proliferation and invasion via the IL6/STAT3 pathway. STAT3 also directly bound the AKR1C3 promoter and increased transcription of AKR1C3, thereby establishing a positive regulatory feedback loop. Treatment with the AKR1C3 inhibitors indocin and medroxyprogesterone acetate inhibited tumor growth and invasion and promoted apoptosis in HCC cells. Collectively, these results indicate that a AKR1C3/NF-κB/STAT3 signaling loop results in HCC cell proliferation and metastasis and could be a promising therapeutic target in HCC. SIGNIFICANCE: These findings elucidate a novel AKR1C3-driven signaling loop that regulates proliferation and metastasis in HCC, providing potential prognostic and therapeutic targets in this disease.
|
巻・号 |
81(5)
|
ページ |
1361-1374
|
公開日 |
2021-3-1
|
DOI |
10.1158/0008-5472.CAN-20-2480
|
PII |
0008-5472.CAN-20-2480
|
PMID |
33361392
|
MeSH |
Aldo-Keto Reductase Family 1 Member C3 / genetics
Aldo-Keto Reductase Family 1 Member C3 / metabolism*
Animals
Carcinoma, Hepatocellular / metabolism
Carcinoma, Hepatocellular / mortality
Carcinoma, Hepatocellular / pathology*
Cell Line, Tumor
Cell Proliferation
Feedback, Physiological
Gene Expression Regulation, Neoplastic
Humans
Interleukin-6 / metabolism
Intracellular Signaling Peptides and Proteins / metabolism
Kaplan-Meier Estimate
Liver Neoplasms / metabolism
Liver Neoplasms / mortality
Liver Neoplasms / pathology*
Male
Mice, Nude
NF-kappa B / metabolism*
Prognosis
STAT3 Transcription Factor / metabolism*
Xenograft Model Antitumor Assays
|
IF |
9.727
|
リソース情報 |
ヒト・動物細胞 |
HuH-7 |